A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis
N Vastesaeger, S Xu, D Aletaha, EW St Clair… - …, 2009 - academic.oup.com
Objectives. Identifying patients with RA at high risk of rapid radiographic progression (RRP)
is critical for making appropriate treatment decisions. We developed an exploratory …
is critical for making appropriate treatment decisions. We developed an exploratory …
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
…, K Reich, FO Nestle, RK Scher, S Li, S Xu… - Journal of the American …, 2008 - Elsevier
BACKGROUND: Although nail psoriasis occurs frequently in patients with psoriatic skin
lesions, effective treatments are limited. OBJECTIVE: Occurrence of nail psoriasis by type and …
lesions, effective treatments are limited. OBJECTIVE: Occurrence of nail psoriasis by type and …
Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
…, J Pazdur, SC Bae, W Palmer, S Xu… - Annals of the …, 2010 - ard.bmj.com
Objective To evaluate the efficacy and safety of golimumab to 52 weeks in patients with active
rheumatoid arthritis despite methotrexate. Methods Patients were randomly assigned to …
rheumatoid arthritis despite methotrexate. Methods Patients were randomly assigned to …
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label …
…, L Imundo, G Simonini, J Oppermann, S Xu… - Annals of the …, 2010 - ard.bmj.com
Objective To assess the long-term efficacy and safety of infliximab plus methotrexate in
juvenile rheumatoid arthritis (JRA). Methods Patients eligible for the open-label extension (OLE, …
juvenile rheumatoid arthritis (JRA). Methods Patients eligible for the open-label extension (OLE, …
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
…, R Inman, A Beutler, Y Zhou, S Xu… - Annals of the …, 2014 - ard.bmj.com
Objective To evaluate radiographic progression in patients with ankylosing spondylitis (AS)
receiving two different doses of the tumour necrosis factor antagonist golimumab. Methods …
receiving two different doses of the tumour necrosis factor antagonist golimumab. Methods …
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
…, RD Inman, D Van Der Heijde, M Mack, S Xu… - Annals of the …, 2012 - ard.bmj.com
Objective To assess the efficacy and safety of golimumab over 104 weeks in patients with
active ankylosing spondylitis. Methods At baseline, patients with active ankylosing spondylitis (…
active ankylosing spondylitis. Methods At baseline, patients with active ankylosing spondylitis (…
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study
S Visvanathan, MU Rahman, GS Hoffman, S Xu… - …, 2011 - academic.oup.com
Objective. To evaluate the association between inflammatory markers and relapse in GCA
patients longitudinally assessed in a clinical trial of infliximab and glucocorticosteroids. …
patients longitudinally assessed in a clinical trial of infliximab and glucocorticosteroids. …
Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid …
…, JJ Cush, RE Chaisson, EL Matteson, S Xu… - Arthritis & …, 2012 - Wiley Online Library
Objective To evaluate the performance of an interferon‐γ release assay (IGRA) versus the
standard tuberculin skin test (TST) as a screening tool for latent tuberculosis (TB) infection …
standard tuberculin skin test (TST) as a screening tool for latent tuberculosis (TB) infection …
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis
…, P Rutgeerts, G Radford-Smith, S Xu… - Inflammatory bowel …, 2007 - academic.oup.com
Background Impairment of health-related quality of life, employment, and productivity has
been documented in patients with moderate to severe ulcerative colitis. Methods Using …
been documented in patients with moderate to severe ulcerative colitis. Methods Using …
Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study
…, AA Deodhar, A Baratelle, S Xu, W Xu… - Annals of the …, 2012 - ard.bmj.com
Objective To evaluate golimumab's effect on MRI-detected spinal inflammation in ankylosing
spondylitis (AS). Methods Patients were randomly assigned to subcutaneous injections of …
spondylitis (AS). Methods Patients were randomly assigned to subcutaneous injections of …